Cohen JA - Search Results

1

Multiple sclerosis management during the COVID-19 pandemic.

Moss BP, Mahajan KR, Bermel RA, Hellisz K, Hua LH, Hudec T, Husak S, McGinley MP, Ontaneda D, Wang Z, Weber M, Tagliani P, Cárdenas-Robledo S, Zabalza A, Arrambide G, Carbonell-Mirabent P, Rodríguez-Barranco M, Sastre-Garriga J, Tintore M, Montalban X, Douglas M, Ogbuokiri E, Aravidis B, Cohen JA, Mowry EM, Fitzgerald KC. Moss BP, et al. Among authors: cohen ja. Mult Scler. 2020 Sep;26(10):1163-1171. doi: 10.1177/1352458520948231. Epub 2020 Aug 10. Mult Scler. 2020. PMID: 32772807 Free PMC article.

2

Management of multiple sclerosis.

Rudick RA, Cohen JA, Weinstock-Guttman B, Kinkel RP, Ransohoff RM. Rudick RA, et al. Among authors: cohen ja. N Engl J Med. 1997 Nov 27;337(22):1604-11. doi: 10.1056/NEJM199711273372207. N Engl J Med. 1997. PMID: 9371858 Review. No abstract available.

3

Multiple sclerosis: the importance of early recognition and treatment.

Fox RJ, Cohen JA. Fox RJ, et al. Among authors: cohen ja. Cleve Clin J Med. 2001 Feb;68(2):157-71. doi: 10.3949/ccjm.68.2.157. Cleve Clin J Med. 2001. PMID: 11220457 Free article.

4

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.

Weiner HL, Cohen JA. Weiner HL, et al. Among authors: cohen ja. Mult Scler. 2002 Apr;8(2):142-54. doi: 10.1191/1352458502ms790oa. Mult Scler. 2002. PMID: 11990872 Review.

5

Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis.

Marrie RA, Miller DM, Chelune GJ, Cohen JA. Marrie RA, et al. Among authors: cohen ja. Mult Scler. 2003 Dec;9(6):621-6. doi: 10.1191/1352458503ms971oa. Mult Scler. 2003. PMID: 14664477

6

Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis.

Marrie RA, Chelune GJ, Miller DM, Cohen JA. Marrie RA, et al. Among authors: cohen ja. Mult Scler. 2005 Feb;11(1):69-75. doi: 10.1191/1352458505ms1110oa. Mult Scler. 2005. PMID: 15732269

7

Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications.

Fox RJ, Fisher E, Tkach J, Lee JC, Cohen JA, Rudick RA. Fox RJ, et al. Among authors: cohen ja. Mult Scler. 2005 Apr;11(2):140-5. doi: 10.1191/1352458505ms1142oa. Mult Scler. 2005. PMID: 15794385 Clinical Trial.

8

A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.

Smith DR, Weinstock-Guttman B, Cohen JA, Wei X, Gutmann C, Bakshi R, Olek M, Stone L, Greenberg S, Stuart D, Orav J, Stuart W, Weiner H. Smith DR, et al. Among authors: cohen ja. Mult Scler. 2005 Oct;11(5):573-82. doi: 10.1191/1352458505ms1210oa. Mult Scler. 2005. PMID: 16193896 Clinical Trial.

9

Multiple sclerosis: treating symptoms, and other general medical issues.

Goldman MD, Cohen JA, Fox RJ, Bethoux FA. Goldman MD, et al. Among authors: cohen ja. Cleve Clin J Med. 2006 Feb;73(2):177-86. doi: 10.3949/ccjm.73.2.177. Cleve Clin J Med. 2006. PMID: 16478042 Free article. Review.

10

Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study.

Miller DM, Cohen JA, Kooijmans M, Tsao E, Cutter G, Baier M. Miller DM, et al. Among authors: cohen ja. Mult Scler. 2006 Apr;12(2):180-6. doi: 10.1191/135248506ms1270oa. Mult Scler. 2006. PMID: 16629421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

717 results

Search Page